New research, published in The Lancet Diabetes and Endocrinology journal, reveals that COVID-related deaths did not increase among people with diabetes due to pandemic-related disruptions. However, the study highlights a rise in complications like sight loss among individuals with diabetes during the pandemic.
The negative impacts were more pronounced among women, younger individuals, and racial or ethnic minorities. The global review, analyzing 138 studies from various regions, emphasizes the importance of ensuring consistent access to diabetes medication and care, especially for vulnerable populations.
The comprehensive study, including researchers from the World Health Organization (WHO), focused on North America, Western Europe, Asia, and other regions. Contrary to concerns, there was no notable increase in COVID-related deaths among people with diabetes during the pandemic. However, the research identified a significant surge in sight loss complications for this group. Disturbingly, the impacts were more pronounced for women, younger individuals, and minority groups, emphasizing the need for targeted support.
Key Concerns:
Co-lead author Jamie Hartmann-Boyce emphasized the importance of addressing the increased risk of severe disease for individuals with diabetes during the pandemic. Alongside a rise in deaths, the study identified a striking increase in diabetes-related admissions to pediatric ICUs and cases of diabetic ketoacidosis (DKA) among children and adolescents. DKA, a potentially life-threatening complication, saw a notable increase during the pandemic, raising concerns about the well-being of children and their families.
The research underscored the critical need for consistent access to diabetes medication and care, especially for vulnerable groups. Reduced access to healthcare during the pandemic led to indirect impacts on diabetes management, including an increase in diabetes-related mortality and all-cause mortality. The study also highlighted an unexpected rise in new cases of Type 1 diabetes, emphasizing the importance of routine primary care visits for early detection.
While the study provides clear evidence of diabetes as a risk factor for severe outcomes from COVID, the researchers stressed the importance of considering these findings in future pandemic planning.
